Page last updated: 2024-11-13
8,9-dihydrobarettin
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
8,9-dihydrobarettin: from sponge Geodia barretti; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 49797534 |
| CHEMBL ID | 514052 |
| MeSH ID | M0465271 |
Synonyms (2)
| Synonym |
|---|
| CHEMBL514052 |
| 8,9-dihydrobarettin |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (2)
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID400227 | Antifouling activity against Balanus improvisus amphitrite assessed as inhibition of cyprid larval settlement at 0.1 to 10 uM after 3 to 4 days relative to control | 2004 | Journal of natural products, Mar, Volume: 67, Issue:3 | Antifouling activity of brominated cyclopeptides from the marine sponge Geodia barretti. |
| AID400228 | Antifouling activity against Balanus improvisus amphitrite assessed as inhibition of cyprid larval settlement | 2004 | Journal of natural products, Mar, Volume: 67, Issue:3 | Antifouling activity of brominated cyclopeptides from the marine sponge Geodia barretti. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
Research
Studies (6)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.56
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.56) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||